FibroGen (NASDAQ:FGEN) will release its quarterly earnings report on Tuesday, 2024-11-12. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate FibroGen to report an earnings per share (EPS) of $-0.30.

The announcement from FibroGen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings Track Record

Last quarter the company beat EPS by $0.10, which was followed by a 4.55% increase in the share price the next day.

Here's a look at FibroGen's past performance and the resulting price change:

Performance of FibroGen Shares

Shares of FibroGen were trading at $0.323 as of November 08. Over the last 52-week period, shares are down 31.24%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for FibroGen visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.